Related references
Note: Only part of the references are listed.Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors
Takayoshi Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Epigenetic therapy in myelodysplastic syndromes
Caterina Musolino et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Epigenetic Changes in the Myelodysplastic Syndrome
Jean-Pierre Issa
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance
Yutao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
Murali Mohan Yallapu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2010)
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)
Donald Lavelle et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
Luca Sigalotti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
Bodo Brueckner et al.
MOLECULAR CANCER THERAPEUTICS (2010)
S110, a 5-Aza-2′-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
Jody C. Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Active DNA demethylation: many roads lead to Rome
Susan C. Wu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme
Katan Patel et al.
NUCLEIC ACIDS RESEARCH (2010)
Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine
Christine Champion et al.
PLOS ONE (2010)
Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors
Lisa A. Cowan et al.
EPIGENOMICS (2010)
How Much? How Frequent? How Long? A Clinical Guide to New Therapies in Myelodysplastic Syndromes
William Blum
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Demethylating Agents in the Treatment of Cancer
Paul M. Howell et al.
PHARMACEUTICALS (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Curcumin is a potent DNA hypomethylation agent
Zhongfa Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Taichun Qin et al.
BLOOD (2009)
Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression
Yinhong Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine
Maryse Lemaire et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Jharna Datta et al.
CANCER RESEARCH (2009)
Multifunctional core-shell magnetic cisplatin nanocarriers
Benjamin Thierry et al.
CHEMICAL COMMUNICATIONS (2009)
Chemical Decomposition of 5-Aza-2′-deoxycytidine (Decitabine): Kinetic Analyses and Identification of Products by NMR, HPLC, and Mass Spectrometry
Daniel K. Rogstad et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
David J. Stewart et al.
CLINICAL CANCER RESEARCH (2009)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
Antonello Mai et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Characterization of azacytidine/poly(L-lactic) acid particles prepared by supercritical antisolvent precipitation
Anna Argemi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased Tumorigenicity
Christopher A. Hamm et al.
PLOS ONE (2009)
Hydrogel nanoparticles in drug delivery
Mehrdad Hamidi et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Susan P. Whitman et al.
BLOOD (2008)
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
Maryse Lemaire et al.
BMC CANCER (2008)
2′-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine:: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase
Hyang-Min Byun et al.
CANCER LETTERS (2008)
Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice
Christine B. Yoo et al.
CANCER PREVENTION RESEARCH (2008)
The colorful history of active DNA demethylation
Steen K. T. Ooi et al.
CELL (2008)
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia
Rebecca B. Klisovic et al.
CLINICAL CANCER RESEARCH (2008)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
The role of DNA hypermethylation and demethylation in cancer and cancer therapy
Moshe Szyf
Current Oncology (2008)
DNA Methylation: Its Role in Cancer Development and Therapy
Carlo Kurkjian et al.
CURRENT PROBLEMS IN CANCER (2008)
Genomic and epigenetic instability in colorectal cancer pathogenesis
William M. Grady et al.
GASTROENTEROLOGY (2008)
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
Mee Young Ahn et al.
GYNECOLOGIC ONCOLOGY (2008)
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Carlo Stresemann et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1
Sabrina Castellano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
J. Devon Roll et al.
MOLECULAR CANCER (2008)
Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines
Carlos M. Galmarini et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine
Gautam Borthakur et al.
LEUKEMIA & LYMPHOMA (2008)
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins
J. D. Young et al.
XENOBIOTICA (2008)
DNA methylation inhibitor 5-aza-2 '-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B
Stela S. Palii et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Genetic interactions between DNA demethylation and methylation in Arabidopsis[OA]
Jon Penterman et al.
PLANT PHYSIOLOGY (2007)
Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy
Robert J. Amato
CLINICAL GENITOURINARY CANCER (2007)
Alu and LINE1 distributions in the human chromosomes: Evidence of global genomic organization expressed in the form of power laws
Diamantis Sellis et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
Kim Appleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M. Candelaria et al.
ANNALS OF ONCOLOGY (2007)
Biodegradable polymers as biomaterials
Lakshmi S. Nair et al.
PROGRESS IN POLYMER SCIENCE (2007)
Delivery of 5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides
Christine B. Yoo et al.
CANCER RESEARCH (2007)
DNA methylation in breast and colorectal cancers
Anshu Agrawal et al.
MODERN PATHOLOGY (2007)
Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines:: SY-5Y neuroblastoma and 293 embryonic kidney (HEK)
Ana-Maria Florea et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
Leukemia targeting ligands isolated from phage display peptide libraries
S. Jaeger et al.
LEUKEMIA (2007)
Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1
Victoria Valinluck et al.
CANCER RESEARCH (2007)
Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer
Ruo-Kai Lin et al.
LUNG CANCER (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
Epigenetics, disease, and therapeutic interventions
Q. Lu et al.
AGEING RESEARCH REVIEWS (2006)
DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia
Allen S. Yang et al.
CANCER RESEARCH (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
E Winquist et al.
INVESTIGATIONAL NEW DRUGS (2006)
Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.
C Stresemann et al.
CANCER RESEARCH (2006)
Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells
X Cui et al.
HUMAN PATHOLOGY (2006)
Epigenetics and human disease: translating basic biology into clinical applications
D Rodenhiser et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Discovery of two novel, small-molecule inhibitors of DNA methylation
P Siedlecki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Procainamide is a specific inhibitor of DNA methyltransferase 1
BH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine
JC Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Characterization of DNA demethylation effects induced by 5-aza-2′-deoxycytidine in patients with myelodysplastic syndrome
C Mund et al.
CANCER RESEARCH (2005)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
T Ben-Kasus et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignancies
MA Rudek et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylation
WE Samlowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Diagnostic and therapeutic applications of epigenetics
K Miyamoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2005)
Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
E Kaminskas et al.
CLINICAL CANCER RESEARCH (2005)
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromes
G Marcucci et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes -: art. no. 44
P Zambrano et al.
BMC CANCER (2005)
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
SA Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FDA drug approval summary:: Azacitidine (5-azacytidine, Vidaza™) for injectable suspension
E Kaminskas et al.
ONCOLOGIST (2005)
DNA methylation and cancer therapy: new developments and expectations
M Esteller
CURRENT OPINION IN ONCOLOGY (2005)
5-Halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)
V Valinluck et al.
NUCLEIC ACIDS RESEARCH (2005)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells
JC Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Biochemistry and biology of mammalian DNA methyltransferases
A Hermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker
JM Teodoridis et al.
DRUG RESISTANCE UPDATES (2004)
Preferential response of cancer cells to zebularine
JC Cheng et al.
CANCER CELL (2004)
Zebularine: a new drug for epigenetic therapy
CB Yoo et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Controlled release systems for DNA delivery
AK Pannier et al.
MOLECULAR THERAPY (2004)
Psammaplins from the sponge Pseudoceratina purpurea:: Inhibition of both histone deacetylase and DNA methyltransferase
IC Piña et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly
DJ Stewart et al.
ANNALS OF ONCOLOGY (2003)
Induction of tumors in mice by genomic hypomethylation
F Gaudet et al.
SCIENCE (2003)
Inhibition of DNA methylation and reactivation of silenced genes by zebularine
JC Cheng et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate
S Faraasen et al.
PHARMACEUTICAL RESEARCH (2003)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
M Daskalakis et al.
BLOOD (2002)
Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases
L Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
JK Christman
ONCOGENE (2002)
Nucleoside analogues and nucleobases in cancer treatment
CM Galmarini et al.
LANCET ONCOLOGY (2002)
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
I Rhee et al.
NATURE (2002)
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality
D Biniszkiewicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug
PD Senter et al.
BIOCONJUGATE CHEMISTRY (2001)
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
CM Galmarini et al.
LEUKEMIA (2001)
Tumor targeting with surface-shielded ligand-polycation DNA complexes
R Kircheis et al.
JOURNAL OF CONTROLLED RELEASE (2001)
The DNA methyltransferases of mammals
TH Bestor
HUMAN MOLECULAR GENETICS (2000)
Isolation of psammaplin A 11 '-sulfate and bisaprasin 11 '-sulfate from the marine sponge Aplysinella rhax
NB Pham et al.
JOURNAL OF NATURAL PRODUCTS (2000)
Share Paper
